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OBJECTIVES The aim of this study was to analyze the clinical findings, course, and treatment of recurrent
pericarditis (RP) in patients with onset in childhood and adolescence.
BACKGROUND Recurrent pericarditis is a chronic condition that has presented problems in management.
Knowledge about this disease is based on observations in adults, and no series of children has
previously been published.
METHODS Fifteen children (nine males, six females) in whom pericarditis had recurred at least twice
were encountered in the period 1985 to 1998. Their age at onset was 6.5 to 16.8 years (mean
11.6 years), and the follow-up was 4.0 to 16.2 years (mean 8.0 years).
RESULTS Recurrent pericarditis was preceded by open-heart surgery by 1 month to 5 years earlier in 7
of 15 patients. The six children with an atrial septal defect (ASD) had an operation at an older
age (mean 9.9 years) than usual (mean 4.8 years). The risk of RP in children operated on for
ASD at the age of six years or later was 5%. An initial attack of pericarditis was associated
with pleuritis and/or pneumonia in 10 of 15 patients and with colitis in 2 of 15 patients
During follow-up, the patients had 2 to 30 recurrences (mean 9.9). Later attacks tended to
be milder. At the end of follow-up, 7 patients had been without attacks for4 years, whereas
after 4 to 16 years, the remaining patients still had active disease. No instance of constriction
was found. Altogether, 11 of 15 patients were treated with corticosteroids. However,
corticosteroids, whether alone or with methotrexate (n  5), azathioprine (n  1),
cyclosporine (n  1), or colchicine (n  4) did not prevent recurrences.
CONCLUSIONS The most frequent background for RP in children was the closure of ASD after the age of six
years. Its course was unpredictable and often chronic, irrespective of the underlying cause or
the therapy given. Colchicine did not prevent relapses. (J Am Coll Cardiol 2003;42:
759–64) © 2003 by the American College of Cardiology Foundation
Recurrences develop in up to 15% to 30% of adult patients
with acute pericarditis (1). Recurrent pericarditis (RP) may
be a debilitating disease resistant to therapeutic interven-
tions (1–6). The etiology of the initial attack, and especially
the cause of recurrences, often remain unclear. Some cases
are connected with chronic inflammatory diseases, and
others are preceded by cardiac operation (2), but the
pericarditis often seems to be idiopathic. Only single chil-
dren with RP have been described (3–8). We report the
clinical findings and follow-up data of 15 children and
adolescents with RP.
METHODS
Patients. This report is based on a retrospective analysis of
15 patients (9 males, 6 females) seen during 1985 to 1998
(Table 1). Their age at the onset of the disease was 6.5 to
16.8 years (mean 11.6 years), and the follow-up time was
4.0 to 16.2 years (mean 8.0 years). Eleven of them were
followed up at the Hospital for Children and Adolescents,
Helsinki.
The initial diagnosis of pericarditis was based on pericar-
dial pain and increased pericardial fluid documented by
echocardiography. Patients were included in our series if the
pericarditis had relapsed at least twice after the initial attack.
Pain and increased pericardial fluid documented recur-
rences, but, in case of several recurrences, diagnoses of last
recurrences were based on typical pain only. The criterion
for a relapse was recurrence of characteristic symptoms and
findings after a period of at least one month since the onset
of the previous attack. Patients with verified systemic
connective tissue diseases were excluded.
We analyzed the following aspects of the disease in the
patients’ records: features of the pericarditis during the
initial attack, number and features of recurrences, clinical
findings, and therapy given. Preceding events such as
cardiac operations and concurrent diseases were recorded. A
comparison was made between postoperative patients and
others and between corticosteroid-treated patients and oth-
ers.
RESULTS
Clinical findings. INITIAL EPISODE. At presentation, 12
children were febrile, and 10 were seriously ill. All had
pericardial pain, mostly in the chest, but also in the
shoulder, back, abdomen, or neck. The average diastolic
thickness of pericardial fluid was 8.3 mm, and one patient
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had mild tamponade. The chest X-ray showed cardiac
enlargement in 14 patients and pleuritis and/or pneumonia
in 10 patients. The electrocardiogram was normal in 3
patients, showed either short-lasting T-wave or ST-
segment changes in 10 patients and low-voltage QRS
complexes in 1 patient. Increased serum creatine kinase-MB
levels were found in three children. The erythrocyte sedi-
mentation rate and C-reactive protein (CRP) values were
clearly elevated (Table 2), except in one patient who had
massive polyserositis.
RECURRENCES. In total, 15 patients had 149 recurrences
(mean 9.9, range 2 to 30) during follow-up (Table 1, Fig. 1).
The principal symptom during recurrences was pain,
similar to that during the initial attack. In only four
patients was pleuritis/pneumonia observed during recur-
rences. In general, with increasing time, recurrences
became less severe and the interval between attacks
became prolonged. This tendency to a milder course was
also seen in cardiologic and laboratory findings, as
summarized in Table 2. In two patients (Patients #3 and
#7), however, clinically mild recurrences gradually devel-
oped into monthly episodes of pericarditis, and in two
patients (Patients #5 and #8), recurrences regained the
initial intensity. None of the recurrences resulted in
tamponade or constrictive pericarditis.
The longest quiescence between attacks was 1 to 11
months (n  6) or 12 to 27 months (n  9). So far, seven
patients have been without further attacks for more than
four years, and these patients may probably be regarded as
cured of RP (Figs. 1 and 2). In this group, active disease,
calculated from the initial attack to the onset of the last
recurrence, lasted from 0.5 to 3.5 years (mean 1.9 years), and
they have been followed up for 4.0 to 11.1 years (mean 6.8
years) after the last recurrence. For those quiescent for 4
years, the active disease has varied from 3.2 to 15.5 years
(mean 6.7 years).
PERICARDIAL FLUID AND HISTOPATHOLOGY. In three pa-
tients, pericardial puncture or drainage was done during the
initial attack and in four during a recurrence without
complications. Pericardial fluid was clear on four occasions,
slightly cloudy once, and slightly bloody twice. Its protein
content was 48 g/l (measured once). The white cell count
varied from 11.4 to 19.5 109/l (60% to 88% polymorpho-
nuclear cells and 12% to 40% mononuclear cells), corre-
sponding to the white cell findings in the blood. In all
samples, bacterial, tuberculous, and fungal cultures were
negative. Viral isolation yielded herpes simplex type 1 in one
sample; however, there was no increase in the viral antibody
titer. Pericardial biopsy displayed fibrosis and nonspecific
inflammation in two patients. Pericardiectomy was not
performed in any of the patients.
Preceding and associated conditions. OPEN-HEART
SURGERY. Open-heart surgery preceded RP in 7 (47%) of
15 patients. An operation was performed for an atrial septal
defect (ASD) in six patients and a ventricular septal defect
in one patient (Table 1). The proportion of ASD patients
(86%) among our postoperative patients with RP was 10
times higher than the 8.4% proportion of ASD operations
among Finnish pediatric cardiac operations in general (9).
Also, the average age at the ASD operation (9.9 years [range
6.3 to 15.7 years]) was higher than that at all ASD
operations (4.8 years) in Finland during the same period.












(months) Associated Conditions During Initial Attack
1 M 16.8 4 ASD 59 Pleuritis, scar irradiation, Rubinstein Taybi syndrome
2 F 10.8 6 VSD 1
3 M 8.4 30 ASD 7 Pneumonia, scarlatina
4 F 10.0 9 ASD 2 Pleuropneumonia
5 M 9.4 13 ASD 22 Pleuropneumonia, appendicectomy
6 M 6.5 2 ASD 3
7 F 15.8 26 ASD 3
8 M 15.5 14
9 M 12.5 10 Pneumonia
10 F 7.5 2 Pleuritis, ascites, thyroiditis
11 M 10.7 2
12 F 6.9 5 Pleuritis, colitis, mesalamine
13 M 15.0 15 Pleuritis
14 M 13.1 5 Pleuropneumonia
15 F 15.4 6 Pleuropneumonia, colitis, erythema-nodosum,
Noonan’s syndrome
ASD  atrial septal defect; VSD  ventricular septal defect.
Abbreviations and Acronyms
ASD  atrial septal defect
CRP  C-reactive protein
NSAID  nonsteroidal anti-inflammatory drug
RP  recurrent pericarditis
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Calculated from the total number of ASD operations
performed during the study period, the risk of RP was 1.6%
and in those who had an operation at the age of six years or
older, 5%. Also, the patient with a ventricular septal defect
was operated on at an older age (9.8 years) than is usual.
Recurrent pericarditis appeared within two years after car-
diac surgery in six children (Table 1). In the patient with an
interval of five years, pericarditis was triggered by radiation
of the keloid thoracotomy scar.
OTHER ASSOCIATED CONDITIONS. The initial attack of
pericarditis was associated with colitis in two children
(Table 1). The disease was of short duration in one patient
(Patient #15), and in the other (Patient #12), ulcerative
colitis was treated with prednisolone and mesalamine. She
had five recurrences of pericarditis, but none after me-
salamine was discontinued. Patient #10 presented with
polyserositis and autoimmune thyroiditis and had a high
titer of antinuclear antibodies, but no definable connective
tissue disease has appeared during follow-up. We aimed at
exclusion of connective tissue diseases by immunologic
studies. Antinuclear antibodies were increased in 1 of 14
patients (Patient #10). Antibodies to extractable nuclear
antigen and to double-stranded deoxyribonucleic acid were
both normal in eight patients studied, as well as rheumatoid
factor in five patients. Serum immunoglobulin levels (n 9)
and complement components C3 and C4 (n  11) were
normal or increased. However, a family history revealed
systemic lupus erythematosus in two families and HLA
B27-positive spondyloarthropathy with carditis in one. The
sister of Patient #10 had autoimmune thyroiditis. The
grandfather of Patient #14 had had several episodes of
pericarditis of unknown etiology.
INFECTIONS IN ASSOCIATION OF THE INITIAL ATTACK AND
RECURRENCES. No microbiologic etiology could be estab-
lished for pleuritis or pneumonia found in 10 of 15 patients
during the initial attack. Blood cultures were obtained in 11
of 15 patients with negative results. Signs of upper respira-
tory tract infection were noted at presentation in four
patients, one of whom had had scarlatina and another had
undergone an appendectomy before the initial attack. An-
tibiotic treatment was administered to nine patients.
Upper respiratory tract infections were recorded in 29
recurrences of 9 patients. An attempt to specify the etiology
of these infections was done only occasionally: influenza A,
Figure 1. Follow-up times in each of the 15 patients. The open part of the bar shows the duration of active disease, and the solid part shows the follow-up
time after the last recurrence. Patient numbers correspond to those in Table 1.
















Initial attack 15 80 60 (10–96) 150 (12–307) 77% (10/13) 100% (15/15)
Relapses 1–3 42 62 62 (4–120) 134 (10–340) 73% (19/26) 89% (34/38)
Relapses 4–6 32 50 46 (13–97) 71 (10–270) 42% (8/19) 59% (16/27)
Relapses 7–9 21 19 17 (7–47) 44 (10–153) 44% (4/9) 43% (3/7)
Relapses 10–15 28 7 39 (7–90) 104 (10–260) 50% (4/8) 42% (5/12)
*Data are presented as the mean value (range).
CRP  C-reactive protein; ECG  electrocardiographic; ESR  erythrocyte sedimentation rate.
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influenza B, adenovirus, parainfluenza 2, and Mycoplasma
pneumoniae infection were all diagnosed once. Interestingly,
Patient #8 had two relapses triggered by influenza vaccina-
tion. In contrast to the initial pericardial attack, pleural
effusion or pulmonary infiltrate was seen only during nine
recurrences. Most recurrences did not have any obvious
triggering factor.
Comparison between postoperative and other cases.
There were no obvious differences in the nature or course of
RP between patients who had an operation for heart disease
and other patients. During the 4-year follow-up of all
patients, the number of recurrences was comparable in the
operated patients (mean 8.1 [range 2 to 26]) and the others
(mean 7.3 [range 2 to 14]). During the initial attack, CRP
was 67 to 307 mg/l (mean 153 mg/l) in the operated
patients and 12 to 295 mg/l (mean 146 mg/l) in the others.
Three of seven postoperative patients and four of eight other
patients were apparently cured of RP during follow-up.
Drug therapy. Four patients (Patients #1, #4, #6, and #9)
were treated with nonsteroidal anti-inflammatory drugs
(NSAIDs) only. The remaining 11 patients received corti-
costeroids, seven of them even during the initial attack. In
two patients, predniso(lo)ne was given as one- to two-week
courses. Long-term (more than two years) prednisolone,
mostly on alternate days, was given to four patients, and in
the rest, the regimen varied. Initially, CRP was 12 to 295
mg/l (mean 135 mg/l) in the group treated with corticoste-
roids and 96 to 307 mg/l (mean 201 mg/l) in the others,
suggesting that the initial attack may not have been less
severe in the group receiving no corticosteroids. During a
follow-up period of 4 years, available in all patients, the
number of recurrences was 2 to 26 (mean 8.3) in the group
treated with corticosteroids and 2 to 6 (mean 4.5) in those
not so treated. Remission of at least 4 years was achieved by
5 of 11 patients of the former group and 2 of 4 of the latter
group. Peroral methotrexate 10 to 15 mg/week in 4 patients
and 25 mg intramuscularly in 1 patient did not prevent
recurrences, neither did azathioprine 100 mg/day in 1
patient. One child (Patient #14) was receiving cyclosporine
A for 9 months and had two more recurrences during that
time, but has since been off treatment and well for 4.5 years.
Colchicine 0.5 to 2.0 mg/day was given to 4 patients
(Patients #3, #5, #7, and #8) who had relapsed despite
corticosteroid treatment. However, these patients had 3 to
10 recurrences (mean 5.8) during a period of 6 to 27 months
(mean 13.3 months) on colchicine. Before colchicine treat-
ment these patients had 4 to 15 attacks (mean 7.5) during a
period of 10 to 71 months (mean 35 months).
DISCUSSION
Open-heart surgery as a background factor. Cardiac
surgery preceded RP in 47% of our patients, in contrast to
the findings in adult series where the proportion of postop-
erative cases varied from 13% (3) to 25% (10). The inci-
dence of post-pericardiotomy syndrome is higher in chil-
dren than in adults (11), which may explain the difference.
On the other hand, post-pericardiotomy syndrome occurs
far more often in older children than in infants (12). In
accordance, all seven postoperative patients had an opera-
tion at an older age than is usual for their defects. The
Registry for Cardiac Operations in Finnish Children al-
lowed us to calculate the risk of RP after ASD operation.
An unexpectedly high 5% risk was found among children
operated on after the age of six years. Altogether, RP seems
to be a disease affecting principally older children and
adolescents. The clinical picture, course, and prognosis of
RP were similar in the postoperative and other patients,
indicating that the character of the trigger is not of
importance for the subsequent nature of the disease.
Figure 2. Total number of patients (whole bar) and patients with active disease (open part of bar) in each follow-up year.
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Associated conditions at the time of initial pericarditis.
Pneumonic infiltration or pleural effusion found in 67% of
our patients may reflect the same immune-mediated process
that inflamed the adjacent pericardium, as no microbiologic
etiology could be verified. In fact, pleuritis is an essential
feature in post-pericardiotomy syndrome (2). Pleuritis
and/or pulmonary infiltration were found both in operated
and nonoperated patients, reflecting the similar pathophys-
iologic mechanism of RP. Two patients had inflammatory
bowel disease, in which pericarditis may very rarely occur as
an extraintestinal manifestation (7). In one of these patients,
both the initial attack and the recurrences of pericarditis
were clearly associated with mesalamine treatment. This
observation stresses the causal role of 5-aminosalicylic acid
compounds in pericarditis, believed to be due to type IV
hypersensitivity reaction, as discussed in detail by Sentongo
and Piccoli (7).
Triggers of recurrences. Clinical documentation of respi-
ratory tract infections was found in patient records in 20% of
all relapses. Mycoplasma infection is among the infections
reported to cause RP (13), but appropriate antibiotic treat-
ment did not prevent further recurrences in our patient.
Interestingly, one patient had relapses repeatedly after
influenza vaccinations, as described previously in an adult
(14). Thus, if pericarditis occurs after influenza vaccination,
further influenza vaccinations should be avoided. It can be
speculated that epi-pericardial injury due to any of a variety
of insults may initiate an autoimmune process, which is
reactivated by microbe-induced immune stimulation. Per-
sistent T-cell activation may be induced by antigens intrin-
sic to the epi-pericardium and cross react with viral antigens
because of molecular mimicry. Coxsackie adenovirus recep-
tors and co-receptors have been described on cardiac cell
surfaces (15).
Genetic factors. Genetic factors may contribute to the
propensity to recurrences in pericarditis. Familial clustering
of RP has recently been described (16), and the grandfather
of one of our patients had RP. The clinical picture of RP
shares features of hereditary recurrent inflammatory disor-
ders, which are characterized by repeated attacks of fever
and organ-localized inflammation affecting mainly the ab-
domen, musculoskeletal system, and skin. In a recent series
of 394 patients with recurrent inflammatory syndrome, 2
patients had RP as the only sign of the disease (17).
Treatment. Controlling chest pain and pericardial effusion
during the attacks and preventing recurrences are the main
goals of therapy. We found no harm in our practice not to
restrict the physical activity of patients between the attacks
when clinical findings were normal. The NSAIDs are the
commonly used first-choice treatment, but the response is
often unsatisfactory, and most patients (11 of 15 in our
series) receive corticosteroids (1,4). Corticosteroids effec-
tively suppress pericardial pain and inflammation during
acute attacks. However, the efficacy of corticosteroids in
preventing relapses has been questioned, and warnings have
been issued about steroid dependence (6,10). Recurrences
occurred in our patients on corticosteroids, and, in fact, the
mean number of relapses in steroid-treated patients was
nearly twice that of those not so treated. Because of systemic
side effects, steroids were discontinued in two patients. The
subsequent relapses were not more frequent and were
successfully treated with NSAIDs only. As the disease
gradually tends to quiet down, it seems possible to avoid
corticosteroids during the later recurrences, even in patients
who initially required them because of intractable symp-
toms. This is especially important in patients with frequent
late recurrences and/or those at risk of steroid dependence,
but without clear-cut evidence of active inflammation, such
as an elevated CRP value. Although the mechanism of pain
in such cases is unknown (possibly due to low-grade
inflammation or so-called complex regional pain syndrome
[18]), pain should be treated with NSAIDs or pain killers
only. None of the other immunosuppressive drugs given to
seven patients prevented recurrences. Thus, we recommend
treatment of children with RP primarily with NSAIDs and
the use of corticosteroids only in those with severe symp-
toms and only temporarily, if possible. As RP is uncommon,
its treatment is challenging. In addition, there is a risk of
steroid dependence, so patients should be followed in
centers familiar with this disease.
Colchicine. Colchicine has recently been used in RP, with
good results in adults and subsequently in children (8,10),
and it has been recommended as the drug of choice in this
disease. In a international multicenter study, 51 patients
were treated with colchicine and only 7 patients (13.7%)
presented with new recurrences (10). Our experience is in
contrast to that study, as the response in all our four patients
was unsatisfactory. Colchicine is an effective drug in familial
Mediterranean fever, a disease prevalent in countries where
good results with colchicine have been obtained in RP.
Mediterranean fever has not been observed in the Finnish
population. The effectiveness of colchicine in RP has not
been tested in a double-blind, controlled manner. This
would be important because of the unpredictable natural
course of RP and the tendency of recurrences to settle down
(Fig. 2).
Prognosis. The course of RP was often long and unpre-
dictable, irrespective of the cause or triggering event. How-
ever, the activity of the disease seems to “burn out” gradually
(Figs. 1 and 2), independent of the type of drug treatment
used. In 7 of 15 patients, remission has lasted for over 4
years. The prognosis of RP may thus be somewhat better in
children than in adults, as only 9 of 31 patients followed by
Fowler and Harbin (3) stayed in remission for 2 years or
more. Mild tamponade was found only in one child. No
instance of constriction appeared.
Study limitations. Recurrent pericarditis is an uncommon
disease in children. The 15 cases of this series were
encountered during a 14-year-long period. Therefore, only
a retrospective analysis of the patients was possible.
Conclusions. The most frequent background for RP in
children was the closure of ASD after the age of six years.
763JACC Vol. 42, No. 4, 2003 Raatikka et al.
August 20, 2003:759–64 Recurrent Pericarditis in Children
The course of RP was unpredictable and often chronic,
irrespective of the underlying cause and therapy given.
Colchicine or other immunosuppressive drugs did not
prevent relapses. Therefore, we prefer the use of NSAIDs in
the treatment of RP in children.
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